SCN2A, encoding the neuronal voltage-gated Na+ channel NaV1.2, is one of the most commonly affected loci linked to autism spectrum disorders (ASDs). Most ASD-associated mutations in SCN2A are loss-of-function mutations, but studies examining how such mutations affect neuronal function and whether Scn2a mutant mice display ASD endophenotypes have been inconsistent. We generated a protein truncation variant Scn2a mouse model (Scn2aΔ1898/+) by CRISPR that eliminates the NaV1.2 channel’s distal intracellular C-terminal domain, and we analyzed the molecular and cellular consequences of this variant in a heterologous expression system, in neuronal culture, in brain slices, and in vivo. We also analyzed multiple behaviors in WT and Scn2aΔ1898/+ mice and correlated behaviors with clinical data obtained in human subjects with SCN2A variants. Expression of the NaV1.2 mutant in a heterologous expression system revealed decreased NaV1.2 channel function, and cultured pyramidal neurons isolated from Scn2aΔ1898/+ forebrain showed correspondingly reduced voltage-gated Na+ channel currents without compensation from other CNS voltage-gated Na+ channels. Na+ currents in inhibitory neurons were unaffected. Consistent with loss of voltage-gated Na+ channel currents, Scn2aΔ1898/+ pyramidal neurons displayed reduced excitability in forebrain neuronal culture and reduced excitatory synaptic input onto the pyramidal neurons in brain slices. Scn2aΔ1898/+ mice displayed several behavioral abnormalities, including abnormal social interactions that reflect behavior observed in humans with ASD and with harboring loss-of-function SCN2A variants. This model and its cellular electrophysiological characterizations provide a framework for tracing how a SCN2A loss-of-function variant leads to cellular defects that result in ASD-associated behaviors.
Hong-Gang Wang, Charlotte C. Bavley, Anfei Li, Rebecca M. Jones, Jonathan Hackett, Yared Bayleyen, Francis S. Lee, Anjali M. Rajadhyaksha, Geoffrey S. Pitt
Title and authors | Publication | Year |
---|---|---|
Restoration of excitation/inhibition balance enhances neuronal signal-to-noise ratio and rescues social deficits in autism-associated Scn2a-deficiency
Zhang J, Eaton M, Chen X, Zhao Y, Kant S, Deming BA, Harish K, Nguyen HP, Shu Y, Lai S, Wu J, Que Z, Wettschurack KW, Zhang Z, Xiao T, Halurkar MS, Olivero-Acosta MI, Yoo YE, Lanman NA, Koss WA, Skarnes WC, Yang Y |
bioRxiv | 2025 |
Disruption of the autism-associated gene SCN2A alters synaptic development and neuronal signaling in patient iPSC-glutamatergic neurons
Brown CO, Uy JA, Murtaza N, Rosa E, Alfonso A, Dave BM, Kilpatrick S, Cheng AA, White SH, Scherer SW, Singh KK |
Frontiers in cellular neuroscience | 2024 |
Exploring the mechanism of agarwood moxa smoke in treating sleep disorders based on GC–MS and network pharmacology
Chen N, Xia Y, Wu W, Chen S, Zhao M, Song Y, Liu Y |
Frontiers in Medicine | 2024 |
Crosstalk among WEE1 Kinase, AKT, and GSK3 in Nav1.2 Channelosome Regulation
Singh AK, Singh J, Goode NA, Laezza F |
International journal of molecular sciences | 2024 |
A neural perspective on the treatment of hypertension: the neurological network excitation and inhibition (E/I) imbalance in hypertension
Xia M, Wang T, Wang Y, Hu T, Chen D, Wang B |
Frontiers in Cardiovascular Medicine | 2024 |
Pathogenic SCN2A variants cause early-stage dysfunction in patient-derived neurons
Asadollahi R, Delvendahl I, Muff R, Tan G, Rodríguez DG, Turan S, Russo M, Oneda B, Joset P, Boonsawat P, Masood R, Mocera M, Ivanovski I, Baumer A, Bachmann-Gagescu R, Schlapbach R, Rehrauer H, Steindl K, Begemann A, Reis A, Winkler J, Winner B, Müller M, Rauch A |
Human Molecular Genetics | 2023 |
Scn2a insufficiency alters spontaneous neuronal Ca2+ activity in somatosensory cortex during wakefulness
Li M, Eltabbal M, Tran HD, Kuhn B |
iScience | 2023 |
Repeat investigation during social preference behavior is suppressed in male mice with prefrontal cortex cacna1c (Cav1.2)-deficiency through the dysregulation of neural dynamics
Hackett J, Nadkarni V, Singh RS, Carthy CL, Antigua S, Hall BS, Rajadhyaksha AM |
2023 | |
Voltage‐gated sodium channels in genetic epilepsy: up and down of excitability
Rusina E, Simonti M, Duprat F, Cestèle S, Mantegazza M |
Journal of Neurochemistry | 2023 |
Gene therapy as an emerging treatment for Scn2a mutation-induced autism spectrum disorders
Ghosh A, Nadella N, Monaghan-Nichols AP, Chu XP |
Fundamental Research | 2023 |
Direct Observation of Compartment-Specific Localization and Dynamics of Voltage-Gated Sodium Channels
Liu H, Wang HG, Pitt G, Liu Z |
Journal of Neuroscience | 2022 |
Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in Scn2aK1422E mice.
Echevarria-Cooper DM, Hawkins NA, Misra SN, Huffman AM, Thaxton T, Thompson CH, Ben-Shalom R, Nelson AD, Lipkin AM, George AL Jr, Bender KJ, Kearney JA |
Human Molecular Genetics | 2022 |
Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum.
Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F |
Physiological reviews | 2022 |
Ionic Channels as Potential Targets for the Treatment of Autism Spectrum Disorder: A Review
Rayff da Silva P, do Nascimento Gonzaga TK, Maia RE, Araújo da Silva B |
Current neuropharmacology | 2022 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |